Clinical use of mood stabilizers beyond treatment for bipolar disorder: The REAP-MS study
Objective: Mood stabilizers are psychotropic drugs mainly used to treat bipolar disorder in the acute phase or for maintenance therapy to prevent relapse. In clinical practice, mood stabilizers are commonly prescribed for conditions other than bipolar disorder. This study investigated the distributi...
Saved in:
Main Author: | Chen C.K. |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2023
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/81576 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Corrigendum to “Clinical use of mood stabilizers beyond treatment for bipolar disorder: The REAP-MS study” [Asian J. Psychiatry 85 (2023) 103613] (Asian Journal of Psychiatry (2023) 85, (S1876201823001685), (10.1016/j.ajp.2023.103613))
by: Chen C.K.
Published: (2023) -
Dosing of Mood Stabilizers for Bipolar Disorder Patients in the Research on Asian Psychotropic Prescription Patterns Consortium Study
by: Yuxi Wang, et al.
Published: (2022) -
Dosing of Mood Stabilizers for Bipolar Disorder Patients in the Research on Asian Psychotropic Prescription Patterns Consortium Study
by: Wang Y.
Published: (2023) -
Clinical Use of Mood Stabilizers With Antidepressants in Asia Report From the Research on Asian Psychotropic Prescription Patterns for Antidepressants (REAP-AD) Projects in 2004 and 2013
by: Kamini Rajaratnam, et al.
Published: (2017) -
Development and validation of a screening instrument for bipolar spectrum disorder: The Mood Disorder Questionnaire Thai version
by: Punjaporn Waleeprakhon, et al.
Published: (2018)